2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015
Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA 2018, 320: 63-71. PMID: 29971398, PMCID: PMC6583049, DOI: 10.1001/jama.2018.8151.Peer-Reviewed Original ResearchConceptsPrimary prevention ICDsNon-Medicare beneficiariesAbsolute decreaseNational Cardiovascular Data Registry ICD RegistrySerial cross-sectional analysisStudy periodImplantable cardioverter defibrillatorRelative decreaseCross-sectional analysisProportion of devicesInitial ICDICD RegistryPrimary preventionCardioverter defibrillatorMAIN OUTCOMEMedicare beneficiariesUS hospitalsHospital groupHospitalICDMore rapid decreasesModest decreaseDepartmentMedicareUS Department
2007
Impact of the Food and Drug Administration’s Public Health Notification on the Adoption of Drug-Eluting Stents
Curtis JP, Cohen DJ, Jones PG, Bach RG, Spertus JA, Krumholz HM. Impact of the Food and Drug Administration’s Public Health Notification on the Adoption of Drug-Eluting Stents. The American Journal Of Cardiology 2007, 99: 1227-1229. PMID: 17478147, DOI: 10.1016/j.amjcard.2006.12.031.Peer-Reviewed Original ResearchConceptsPublic health notificationDrug-eluting stentsDES useDrug Administration Public Health NotificationsUse of DESDrug Administration NotificationProspective registryMyocardial infarctionDES safetyClinical practiceStudy periodStentsRelative decreaseTemporary effectInfarctionPatientsNotificationFoodRegistryDramatic increase